Celgene's most recent trend suggests a bearish bias. One trading opportunity on Celgene is a Bear Call Spread using a strike $108.00 short call and a strike $113.00 long call offers a potential 29.2% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $108.00 by expiration. The full premium credit of $1.13 would be kept by the premium seller. The risk of $3.87 would be incurred if the stock rose above the $113.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Celgene is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Celgene is bearish.
The RSI indicator is at 30.63 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
Agios Stock Soars As Partner Celgene Preps Drug Filing
Wed, 07 Sep 2016 20:40:24 GMT
Celgene Shows Spending Pays
Wed, 07 Sep 2016 19:11:16 GMT
This Celgene Cancer Treatment Could Lead the Industry by 2021
Wed, 07 Sep 2016 19:04:05 GMT
Celgene’s Enterprise Value to Earnings in Line with Peers
Wed, 07 Sep 2016 18:04:08 GMT
Why Agios Pharmaceuticals Inc Stock Skyrocketed Today
Wed, 07 Sep 2016 17:45:47 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook